 | This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages)
|
Denis Francis Kinane | |
|---|---|
 | |
| Born | January 29, 1957 |
| Nationality | British |
| Alma mater | University of Edinburgh |
| Occupation(s) | Immunologist, Cell Biologist, Infection, Immunity and Genomics Specialist |
Denis Francis Kinane (born 29 January 1957) is a Scottish immunologist, cell biologist, infection, immunity and genomics specialist. He is the author of more than 250 papers with an H-index of 82, and editor of Nature[1] and Springer[2] journals. Kinane has held professorial appointments in pathology, periodontology, immunology, infection and immunity at medical and dental schools in the UK, United States and Switzerland. He is a director of two large US[3] and Chinese[4] health companies and Scientific Director, CMO and founder of several smaller international companies.
Kinane is a Co-Founder and Chief Medical Officer at Cignpost Diagnostics Ltd,[5] a UK based Covid-19 testing company specialising in rapid delivery of Gold standard PCR testing.
- ^ Kinane, Denis (14 September 2017). "Authors' reply: Predictive diagnostic tests in periodontal diseases". Nature Reviews. 3: 17070. doi:10.1038/nrdp.2017.70. PMID 28905942. S2CID 38140677.
- ^ Kinane, Denis (1 March 2021). "Current Oral Health Reports" (1). Springer. Retrieved 21 February 2021.
{{cite journal}}: Cite journal requires|journal=(help) - ^ Kinane, Denis. "Mid-Atlantic Dental". Mid-Atlantic Dental. Retrieved 21 February 2021.
- ^ Kinane, Denis. "Arrial Dental". Retrieved 21 February 2021.
- ^ "Government to increase use of lateral flow devices for mass Covid testing". The Telegraph. Retrieved 21 February 2021.